Sellas Life Sciences Group Inc (SLS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SLS Giù? Forum Previsione Frazionamento azionario

Sellas Life Sciences Group Inc Azioni (SLS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	0.079	-	-	-	-
Cost Of Revenue	-	-	-	-	-
Operating Expenses	9.724	-	-	-	-
Benefits Costs and Expenses	9.645	-	-	-	-
Costs And Expenses	17.95% 9.645	8.177	9.361	9.05	11.28
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	17.95% -9.645	-8.177	-9.361	-9.05	-11.28
Net Interest Income/Expense	92.68% 0.079	0.041	0.094	0.208	0.182
Nonoperating Income/Loss	92.68% 0.079	0.041	0.094	0.21	0.184
Income/Loss From Continuing Operations Before Tax	25.08% -9.566	-7.648	-9.361	-9.05	-11.28
Income/Loss From Continuing Operations After Tax	17.58% -9.566	-8.136	-9.267	-8.84	-11.10
Net Income/Loss	17.58% -9.566	-8.136	-9.267	-8.84	-11.10
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,340% 44.81	1.0092	28.36	28.35	23.55
Diluted Average Shares	4,340% 44.81	1.0092	28.36	28.35	23.55
Basic Earnings Per Share	16.00% -0.21	-0.25	-0.33	-0.31	-0.47
Diluted Earnings Per Share	16.00% -0.21	-0.25	-0.33	-0.31	-0.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%